Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-05 · accession 0001649094-24-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-06 | 2024-11-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $106.36 | -5,000 | 28.6K | -15% | -$531.8K |
| D | 2024-11-06 | 2024-11-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.6K | +17% | +$107.0K |
| D | 2024-11-06 | 2024-11-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -5,000 | 164.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-05 | S | D | 788 | $104.80 | 32,835 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $104.345 to $105.33. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-11-05 | S | D | 1,415 | $105.72 | 31,420 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $105.35 to $106.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-11-05 | S | D | 1,524 | $106.82 | 29,896 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $106.38 to $107.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-11-05 | S | D | 1,273 | $107.50 | 28,623 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $107.39 to $107.745. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-11-05 | M | A | 5,000 | $21.41 | 33,623 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-11-05 | M | D | 5,000 | $0.00 | 164,497 | D | $21.41 · — to 2032-05-08 | 5,000 Common Stock | (F6) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |